Latest Posts › USPTO

Share:

Navigating Key Differences in Therapeutic Antibody Patent Protection Strategies Between the United States and Europe

Many of today’s top-selling drugs worldwide are therapeutic antibodies thus antibody-related inventions can be extremely valuable. Developing antibody therapeutics requires significant resources and time, so it is paramount...more

Late But Not Too Late | Submitting Post-Filing Data During Patent Prosecution in Selected Jurisdictions

Intellectual Property counsel often face the dilemma of when to file a patent application: as soon as possible, or wait and gather more support? Filing an application “early” helps to avoid anticipatory prior art but if the...more

USPTO Announces COVID-19 Provisional Application Pilot Program

The United States Patent and Trademark Office (USPTO) announced a new COVID-19 Provisional Application Pilot Program (PAPP) on Wednesday, September 16, 2020. The USPTO will defer the provisional application filing fees for up...more

U.S. Patent and Trademark Office Again Extends Certain Deadlines to September 29, But Still Only For Some.

Section 12004 of the CARES Act allows the director of the United States Patent & Trademark Office (USPTO) (under certain conditions) to provide temporary relief from certain USPTO filing deadlines and fees. ...more

U.S. Patent and Trademark Office Extends Certain Deadlines to July 1, For Some.

Section 12004 of the CARES Act allows the director of the United States Patent & Trademark Office (USPTO) (under certain conditions) to provide temporary relief from certain USPTO filing deadlines and fees....more

USPTO COVID-19 Prioritized Examination Pilot Program (PEPP) Announced

UPDATED: MAY 13, 2020: Although the USPTO Notice published on May 8, 2020, the Federal Register Notice, upon which the PEPP program is effective, will publish tomorrow, May 14, 2020 (and will be accessible here). The USPTO...more

Further Extensions for EPO Deadlines Available (Updated)

We previously published an alert that the European Patent Office (EPO), the European Union Intellectual Property Office (EUIPO) and United States Patent and Trademark Office (USPTO) had issued Notices that extended the times...more

CARES Act - U.S. Patent and Trademark Office Extends Certain Deadlines to June 1

Section 12004 of the CARES Act allows the director of the United States Patent & Trademark Office (USPTO) (under certain conditions) to provide temporary relief from certain USPTO filing deadlines and fees. ...more

Further Extensions for EPO Deadlines Available

We previously published an alert that the European Patent Office (EPO), the European Union Intellectual Property Office (EUIPO) and United States Patent and Trademark Office (USPTO) had issued Notices that extended the times...more

CARES Act | US Patent and Trademark Office - Additional Extensions Available

The Coronavirus Aid, Relief, and Economic Security Act (CARES Act), enacted last week, contains several provisions which are intended to provide resources and assistance for a number of businesses impacted by the current...more

“Patents 4 Patients”: A New Cancer Immunotherapy “Fast Track” for U.S. Patent Applicants

In connection with the White House Cancer Moonshot Initiative, the United States Patent and Trademark Office (“USPTO”) announced on June 29 that it is “Teaming Up to Cure Cancer” by establishing a new accelerated process for...more

11 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide